Logmore, a Finnish provider of supply chain analytics solutions, announced on Wednesday the launch of a new logistics monitor designed for COVID-19 vaccine delivery.
Logmore Dry Ice, a high-spec version of the company's original data recorder, has been adapted for cold and sub-zero conditions. It is designed for sensitive shipments such as COVID-19 vaccines which require deep freeze storage of as low as -80ºC throughout their journey.
The logger has an additional sensor connected to it with a cable. By placing only the external sensor inside the box, the device can monitor internal temperatures despite remaining outside the box -- allowing it to handle far lower temperatures than comparable products.
The device's ability to monitor temperature, humidity, shocks, tilt and light in real-time will help ensure that life-saving vaccines can be distributed in optimum condition, Logmore said.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses